MedTrace Logo

Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection

NCT01771653 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2016-01-18

No results posted yet for this study

Summary

The purpose of this observational study is to compare two approved treatment regimen(s) containing boceprevir and telaprevir, as part of standard of care for the treatment of hepatitis C.

Conditions

  • Hepatitis C Infection

Sponsors & Collaborators

  • Southern Illinois University

    lead OTHER

Principal Investigators

  • Janak Koirala, MD, MPH · Southern Illinois University School of Medicine

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01771653 on ClinicalTrials.gov